Literature DB >> 26584029

Evidence and Consensus on the Management of Hepatocellular Carcinoma: Update 2015.

Masatoshi Kudo1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26584029     DOI： 10.1159/000440624

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  6 in total

1.  Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.

Authors:  Yuan Cheng; Lei Luo; Juqiang Zhang; Mantian Zhou; Yujun Tang; Guolin He; Yishi Lu; Zhong Wang; MingXin Pan
Journal:  J Gastrointest Surg       Date:  2019-02-25       Impact factor: 3.452

2.  Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Ningbin Luo; Wenzhu Li; Jisheng Xie; Danhui Fu; Lidong Liu; Xiangyang Huang; Danke Su; Guanqiao Jin
Journal:  Eur Radiol       Date:  2020-10-09       Impact factor: 5.315

3.  Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.

Authors:  Qian Zhang; Wanting Xing; Jie Zhang; Junwen Hu; Lunan Qi; Bangde Xiang
Journal:  Onco Targets Ther       Date:  2021-03-02       Impact factor: 4.147

4.  Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma.

Authors:  Yun-Long Lu; Jin-Guang Yao; Xiao-Ying Huang; Chao Wang; Xue-Min Wu; Qiang Xia; Xi-Dai Long
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

5.  Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.

Authors:  Xiaoting Song; Ailu Wu; Zhixiao Ding; Shixiong Liang; Chunyan Zhang
Journal:  Cancer Res Treat       Date:  2020-03-05       Impact factor: 4.679

6.  Micro RNA-4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy.

Authors:  Tian-Qi Zhang; Qun-Qing Su; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Qiang Xia; Xi-Dai Long; Yun Ma
Journal:  Hepatol Commun       Date:  2018-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.